Cure My Disease

Don't miss your cure!

 Log in / Sign up

Psychiatric patients get the keys: Self-Admission trial aims to cut forced care

NCT ID NCT04862897

Disease control Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether allowing patients with severe psychiatric conditions to admit themselves to inpatient care (up to 4 days at a time, 3 times per month) can reduce involuntary admissions and improve quality of life. Over 500 participants in Stockholm will be followed, comparing outcomes like days in hospital and use of coercive measures. The goal is to empower patients and decrease the need for forced treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient-controlled admissions (self-admission to inpatient care)
What this could lead to
If successful, this approach could give patients more autonomy and reduce the need for involuntary hospitalizations and coercive measures.
What could go wrong
This is a large implementation study, but results depend on patient selection and adherence. It may not reduce overall hospital use or could increase it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 564 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2020

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients with severe psychiatric conditions in Region Stockholm who fulfil the inclusion criteria can be provided access to patient-controlled admissions. This includes child and adolescent psychiatry, but excludes forensic psychiatry and addiction care. All patients who receives patient-controlled admissions and a matched control group will be evaluated regarding all primary outcome measures, other psychiatric or somatic healthcare consumption, sick-leave, and redeemed medical prescriptions. For the remaining secondary outcomes measures (i.e., self-reported outcomes), only those patients who consent to participate in the research project will be evaluated.

Ages

15 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have an on-going contact with outpatient care. * Have an individual care plan and crisis plan. * Have had at least one inpatient care period the previous year. * Are expected to have the greatest need of inpatient care. * Are interested in, and understand the concept of, patient-controlled admissions. Exclusion Criteria: * No informed consent to participate in the research project (concerns only self-reported outcomes). Matched control group: \- A matched control group consisting of seven times the number of of patients receiving patient-control admissions will be utilised for all primary outcome measures, other psychiatric or somatic healthcare consumption, sick-leave, and redeemed prescriptions (matched on account of age, gender, diagnosis, and history of psychiatric inpatient care, but who have not been granted access to patient-controlled admissions)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Matched control group are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Matched control group Patient-controlled admissions

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre for Psychiatry Research

    RECRUITING

    Stockholm, Stockholm County, 113 64, Sweden